-
Antibodies, Research Grade BiosimilarsOmalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C020P.LA
$650.00Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Palivizumab Biosimilar, N297A Mutant | C021P.NA
$650.00Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C021P.LA
$650.00Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05
$720.00 – $1,440.00Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Panitumumab Biosimilar, N297A Mutant | C012P.NA
$650.00Panitumumab Biosimilar, N297A Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Panitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C012P.LA
$650.00Panitumumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Panitumumab Biosimilar, Endotoxin 0.05 EU/mg | C012P.05
$720.00 – $1,440.00Panitumumab Biosimilar, Endotoxin 0.05 EU/mg. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Eculizumab Biosimilar, N297A Mutant | C022P.NA
$650.00Eculizumab Biosimilar, N297A Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Eculizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C022P.LA
$650.00Eculizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Infliximab Biosimilar, N297A Mutant | C011P.NA
$375.00Infliximab Biosimilar, N297A Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Infliximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C011P.LA
$375.00Infliximab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Camrelizumab Biosimilar, Anti-human PD-1 Antibody | C028P
$175.00 – $1,600.00Camrelizumab Biosimilar, PD-1 Monoclonal Antibody. The research grade Camrelizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and…
Select optionsQuick View
Shop by Category
